White, M. C., Schroeder, R. D., Zhu, K., Xiong, K., & McConkey, D. J. (2018). HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells. Oncogene.

White, Matthew C., Rebecca D. Schroeder, Keyi Zhu, Katherine Xiong, و David J. McConkey. "HRI-mediated Translational Repression Reduces Proteotoxicity and Sensitivity to Bortezomib in Human Pancreatic Cancer Cells." Oncogene 2018.

White, Matthew C., et al. "HRI-mediated Translational Repression Reduces Proteotoxicity and Sensitivity to Bortezomib in Human Pancreatic Cancer Cells." Oncogene 2018.